Washington Trust Bank Has $15.63 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Washington Trust Bank reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 4.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 30,892 shares of the healthcare conglomerate's stock after selling 1,439 shares during the period. UnitedHealth Group makes up approximately 1.5% of Washington Trust Bank's holdings, making the stock its 22nd biggest holding. Washington Trust Bank's holdings in UnitedHealth Group were worth $15,627,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in UNH. NewSquare Capital LLC acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $25,000. AlphaMark Advisors LLC bought a new position in UnitedHealth Group in the fourth quarter valued at $30,000. Promus Capital LLC bought a new stake in UnitedHealth Group during the 4th quarter worth about $32,000. RPg Family Wealth Advisory LLC bought a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $37,000. Finally, Pillar Financial Advisors LLC acquired a new position in UnitedHealth Group during the fourth quarter valued at approximately $40,000. Institutional investors and hedge funds own 87.86% of the company's stock.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the company's stock in a transaction dated Friday, January 17th. The stock was purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company's stock, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.33% of the stock is owned by corporate insiders.

Remove Ads

UnitedHealth Group Price Performance

UnitedHealth Group stock traded up $4.67 during mid-day trading on Wednesday, reaching $518.10. 3,253,715 shares of the company were exchanged, compared to its average volume of 4,082,722. The firm has a market cap of $473.92 billion, a PE ratio of 33.43, a PEG ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a fifty day simple moving average of $509.10 and a 200-day simple moving average of $545.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the prior year, the company posted $5.83 earnings per share. The business's revenue for the quarter was up 6.8% on a year-over-year basis. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.62%. UnitedHealth Group's payout ratio is 54.19%.

Analysts Set New Price Targets

Several equities research analysts have recently commented on UNH shares. Truist Financial decreased their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research note on Monday, January 6th. Hsbc Global Res upgraded shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 10th. Wells Fargo & Company lowered their price target on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 28th. StockNews.com upgraded UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Thursday, January 23rd. Finally, HSBC raised UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price target for the company in a report on Friday, January 10th. Twenty investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Buy" and a consensus price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.